Publications

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Alignment of New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Framework for Action

January 5, 2013

Tuberculosis Comorbidity with Communicable and Non-Communicable Diseases: Integrating Health Services and Control Efforts

January 4, 2013

Zero Deaths from Tuberculosis: Progress, Reality, and Hope

January 4, 2013

Tuberculosis Biomarkers Discovery: Developments, Needs, and Challenges

Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test

Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium

The advantages of frontotemporal degeneration drug development (Part 2 of frontotemporal degeneration: the next therapeutic frontier)

Global standardization measurement of cerebral spinal fluid for Alzheimer’s disease: an update from the Alzheimer’s Association Global Biomarkers Consortium

March 1, 2013

Critical Path Institute’s Electronic Patient-Reported Outcome Consortium

March 1, 2013

The Patient-Reported Outcome (PRO) Consortium at the Critical Path Institute (C-Path)

Previous2829 30...32 Next